Description: The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Exchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 87.09 | 0.00 | 87.09 |
| Stock non-US | 11.19 | 0.00 | 11.19 |
| Cash | 1.72 | 0.00 | 1.72 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 99.34 | 99.57 |
| Basic Materials | 0.66 | 0.10 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 91.95 | 92.60 |
| Europe Developed | 5.47 | 4.28 |
| United Kingdom | 1.39 | 1.65 |
| Asia Emerging | 1.19 | 0.82 |
| Japan | 0.00 | 0.54 |
| Australasia | 0.00 | 0.11 |
| Africa/Middle East | 0.00 | 0.02 |